NG GEORGE K (Chief Executive Officer) purchased 141.2% of their position (2.14K shares) of PROCESSA PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $5.4K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/1/2026ACC: 0000897069-26-000750
Officer· Chief Executive Officer
Since Aug 2023
+2.14K
Net shares
Net buyer
$5.4K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2.14K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.14K
Price / share
$2.54
Trade value
$5.41K
% of position
141.2%
3/31/2026
1.51K→3.65K
Total
Net shares
+2.14K
Net value
$5.41K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/31/2026 | P · Purchase | +2.14K | $2.54 | $5.41K | 141.2% | 1.51K | 3.65K |
| Total | +2.14K | $5.41K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned800.00
Common Stock
IndirectShares owned3.49K
Total
4.29K indirect4.29K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 800.00 | Indirect |
| Common Stock | 3.49K | Indirect |
| Total | 4.29K | 4.29K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported